Lipid measures are associated with cognitive functioning in multiple sclerosis patients
Our results suggest a mild negative impact of dyslipidemia on cognitive performance in patients with MS. We propose that dyslipidemia contributes, at least in part, to cognitive decline in MS patients, independent of brain atrophy.
Authors
- Balázs B. Lőrincz
- Manuela Vaněčková (ORCID: https://orcid.org/0000-0002-8784-7997)
- Dana Horáková (ORCID: https://orcid.org/0000-0003-1915-0036)
- Tomáš Uher (ORCID: https://orcid.org/0000-0003-3160-9022)
- Jan Krásenský (ORCID: https://orcid.org/0000-0002-5605-8821)
- Lucie Friedová (ORCID: https://orcid.org/0000-0002-6398-4540)
- Jiří Motýl (ORCID: https://orcid.org/0000-0002-7315-1251)
- Bénédicte Maréchal (ORCID: https://orcid.org/0000-0001-7866-2854)
- Tobias Kober (ORCID: https://orcid.org/0000-0001-7598-9456)
- Michal Vráblík (ORCID: https://orcid.org/0000-0002-7226-1926)
- Daniel Hrych
- Tadeáš Urban
- Eva Kubala Havrdová
Institutions
- Charles University (CZ)
- Siemens Healthcare (United States) (US)
- General University Hospital in Prague (CZ)
Publication Details
- Journal
- Multiple Sclerosis and Related Disorders
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1016/j.msard.2024.105879
- Citations
- 2
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- European Commission
- Ministerstvo Školství, Mládeže a Tělovýchovy
- Ministerstvo Zdravotnictví Ceské Republiky
- Všeobecná Fakultní Nemocnice v Praze